Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia-Pacific Modified Delphi Expert Panel Recommendations

    February 2026 in “ International Journal of Dermatology ”
    Rodney D. Sinclair, Chao‐Chun Yang, Wen‐Hung Chung … Cheng Zhou
    Studysummary This consensus provides a framework for standardized diagnosis and treatment of alopecia areata in the Asia Pacific region, recommending specific therapies based on age and disease severity.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 31

    1. Short-Term Malignancy Risk of JAK Inhibitors in Severe Alopecia Areata: A Multicenter Cohort Study Archives of Dermatological Research · 2025
    2. Local Corticosteroids for Alopecia Areata: A Narrative Review Dermatology and Therapy · 2025
    3. Alopecia Areata: Pathogenesis, Diagnosis, And Therapies MedComm · 2025
    4. Global Burden of Alopecia Areata and Associated Diseases: A Trend Analysis From 1990 to 2021 PubMed · 2025
    5. Taiwanese Dermatological Association Consensus on the Diagnosis and Management of Alopecia Areata Dermatologica Sinica · 2025
    6. The Role of Minoxidil in the Treatment of Alopecia Areata: A Systematic Review and Meta-Analysis Journal of Clinical Medicine · 2024
    7. Efficacy and Safety of the Oral Janus Kinase 3/Tyrosine Kinase Inhibitor Ritlecitinib Over 24 Months: Integrated Analysis of the ALLEGRO Phase IIb/III and Long-Term Phase III Clinical Studies in Alopecia Areata British Journal of Dermatology · 2024
    8. British Association of Dermatologists Living Guideline for Managing People with Alopecia Areata 2024 British Journal of Dermatology · 2024
    9. Lifetime Incidence and Healthcare Disparities in Alopecia Areata: A UK Population-Based Cohort Study British Journal of Dermatology · 2024
    10. Efficacy and Safety of Deuruxolitinib, an Oral Selective Janus Kinase Inhibitor, in Adults with Alopecia Areata: Results from the Phase 3 Randomized, Controlled Trial (THRIVE-AA1) Journal of the American Academy of Dermatology · 2024
    11. Epidemiology, Treatment Patterns, And Healthcare Resource Utilization Study Of Patients With Alopecia Areata In Taiwan's National Health Insurance Research Database Value in Health Regional Issues · 2024
    12. The Alopecia Areata Severity And Morbidity Index (ASAMI) Study JAMA Dermatology · 2024
    13. Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program American journal of clinical dermatology · 2024
    14. European Expert Consensus Statement on the Systemic Treatment of Alopecia Areata JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology · 2024
    15. Efficacy and Adverse Effects of Corticosteroid Pulse Therapy in Alopecia Areata Dermatology practical & conceptual · 2023
    16. Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review Dermatology and therapy · 2023
    17. Effective Counseling of Patients With Hair Loss Journal of the American Academy of Dermatology · 2023
    18. Janus Kinase Inhibitors For Alopecia Areata JAMA network open · 2023
    19. Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata Over 52 Weeks in Phase III Trials American Journal of Clinical Dermatology · 2023
    20. The Burden of Alopecia Areata: A Scoping Review Focusing on Quality of Life, Mental Health, and Work Productivity Journal of the European Academy of Dermatology and Venereology · 2023
    21. Systematic Review of Psychological Interventions for Quality of Life, Mental Health, and Hair Growth in Alopecia Areata and Scarring Alopecia Journal of Clinical Medicine · 2023
    22. Guidelines for the Management of Patients with Alopecia Areata in Korea: Part II Systemic Treatment Annals of Dermatology · 2023
    23. Prevalence, Comorbidities, and Treatment Patterns of Japanese Patients with Alopecia Areata: A Descriptive Study Using Japan Medical Data Center Claims Database The Journal of Dermatology · 2022
    24. Epidemiological Trends in Alopecia Areata at the Global, Regional, and National Levels Frontiers in immunology · 2022
    25. Alopecia Areata: A Review of Diagnosis, Pathogenesis, and the Therapeutic Landscape Wound practice & research · 2022
    26. Quality of Life Measurement in Alopecia Areata: Position Statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient-Oriented Outcomes Journal of the European Academy of Dermatology and Venereology · 2021
    27. Utility of Azathioprine, Methotrexate, and Cyclosporine as Steroid-Sparing Agents in Chronic Alopecia Areata: A Retrospective Study of Continuation Rates in 138 Patients JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology · 2020
    28. Efficacy of Different Concentrations of Intralesional Triamcinolone Acetonide for Alopecia Areata: A Systematic Review and Meta-Analysis Journal of the American Academy of Dermatology · 2019
    29. Treatment of Alopecia Areata: An Australian Expert Consensus Statement Australasian journal of dermatology · 2018
    30. Intravenous Methylprednisolone Pulse Therapy in Severe Alopecia Areata Indian journal of dermatology, venereology, and leprology · 2015
    31. Alopecia Areata: Clinical Presentation, Diagnosis, and Unusual Cases Dermatologic Therapy · 2011